Patents
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
06/2008
06/05/2008WO2008043788A3 Novel compounds
06/05/2008WO2008043075A3 Compositions for the treatment of scleritis
06/05/2008WO2007103839A3 Pyrrolotriazine aniline prodrug compounds useful as kinase inhibitors
06/05/2008US20080132706 Compounds as PDE IV and TNF Inhibitors
06/05/2008US20080132704 3-Substituted quinuclidines and their use
06/05/2008US20080132678 Such as N-(4-morpholine)carbonyl-(O-benzyl)-L-tyrosine-L-leucine boronic acid for reducing rate of degradation of proteins; proteasome inhibitors
06/05/2008US20080132574 Leukotriene B4 receptor binding activity; treatment of skin disease such as psoriasis, eczema, skin cancer, keratosis, dyspigmentation or psilosis
06/05/2008US20080132543 Therapeutic and Delivery Methods of Prostaglandin Ep4, Agonists
06/05/2008US20080132537 Viricides; antiinflammatory agents; infection therapy; respiratory system disorders
06/05/2008US20080132531 Synergistic combinations of norketamine and opioid analgesics
06/05/2008US20080132526 Purine Derivative
06/05/2008US20080132513 new mechanism of action, oral bioavailability and/or reduced side effects; Ca2+-release-activated Ca2+ channels inhibitors; IL-2, IL-4, IL-5, IL-13, GM-CSF, TNF- alpha , and IFN gamma inhibitors; immunosuppressant
06/05/2008US20080132506 Anti-inflammatory medicaments
06/05/2008US20080132505 Combination Of Cb2 Modulators And Pde4 Inhibitors For Use In Medicine
06/05/2008US20080132504 2, 4-Pyrimidinediamines Useful In The Treatment Of Neoplastic Diseases, Inflammatory And Immune System Disorders
06/05/2008US20080132493 Aqueous cyclodextrin-free solution; analgesics, antiinflammatories, antipyretics
06/05/2008US20080132481 Use of 3-substituted amino-2-carboxy-substituted indoles or benzo(b)thiophenes or esters thereof that modulate T helper (Th) cells; treating allergy, asthma, rhinitis, dermatitis, B-cell lymphomas, tumors and diseases associated with bacterial, rhinovirus or respiratory syncytial virus (RSV) infections
06/05/2008US20080131931 Expression vector comprising nucleotide sequences coding protein which binds interleukin-10 related t cell-derived inducible factor (IL-TIF); for use in targeting cell for surgical removal
06/05/2008US20080131871 Using vector comprisng nucleotide sequences coding cell binding elements to transform cells and identify lymphocyte response modulators
06/05/2008US20080131565 Edible composition; partially defatted cocoa solids prepared by heating slaty and/or purple cocoa beans, winnowing the cocoa nibs from the cocoa shells; pressing the cocoa nibs to produce cocoa butter, recovering the cocoa butter and solids; adding the recovered, defatted cocoa solids
06/05/2008US20080131475 Stenosis, restenosis; active agent polymer matrix coated stents; easy adaptation of required drug release rate
06/05/2008US20080131426 Using kallikren specific immunoglobulin as therapeutic tool in treating cardiocascular disorders; tissue repair
06/05/2008US20080131424 Method of treatment and agents useful for same
06/05/2008US20080131423 Triggering receptors expressed on myeloid cells (TREMs) specific immunoglobulin for use in prevention and treatment of blood coagulation disorders
06/05/2008US20080131420 Methods and compositions for treating mucosal inflammation
06/05/2008US20080131417 Microarray-based analysis of rheumatoid arthritis markers
06/05/2008US20080131410 Placental stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
06/05/2008US20080131402 Controlled Production and Delivery of Biologically Active Agents by Gut Bacteria
06/05/2008US20080131399 Using interferon alpha chimera to treat and prevent cell proliferative and viral diseases
06/05/2008US20080131374 Pneumococcal vaccine and tumor necrosis factor antibodies; c-reactive protein; drug screening
06/05/2008US20080131370 For prophylaxis or treatment of apoptosis or inflammation-associated disease, diabetes, or chronic obstructive pulmonary disease
06/05/2008CA2672327A1 Aza-indolyl compounds and methods of use
06/05/2008CA2670957A1 Modulation of prostaglandin/cyclooxygenase metabolic pathways
06/05/2008CA2670774A1 Substituted piperizines for the treatment of pain
06/04/2008EP1927659A1 Wisp polypeptides and therapeutical applications thereof
06/04/2008EP1927367A1 Novel pharmaceutical using anti-hla antibody
06/04/2008EP1927352A2 Therapeutic methods and compositions involving isoflavones
06/04/2008EP1926708A1 Biaryl substituted heterocycle inhibitors of lta4h for treating inflammation
06/04/2008EP1926477A1 Composition comprising a nsaid and paracetamol
06/04/2008EP1562566B1 Analgesic compositions comprising nmda receptor antagonists and benzalkonium chloride
06/04/2008EP1487817B1 Piperidine derivatives useful as modulators of chemokine receptor activity
06/04/2008EP1463754B1 Cystine-knot fold protein
06/04/2008EP1392688B1 Pyrazino[1',2':1,6]-pyrido[3,4-b] indole-1,4-dione derivatives
06/04/2008EP1237887B1 9-(piperazinylalkyl)carbazoles as bax-modulators
06/04/2008EP0672143B1 Lymphotoxin-beta, lymphotoxin-beta complexes, pharmaceutical preparations and therapeutic uses thereof
06/04/2008CN101193883A 2,6 quinolinyl derivatives, processes for preparing them and their use as medicament
06/04/2008CN101193560A A combination of seal oil and cold-pressed virgin olive oil
06/04/2008CN101190937A Compound with liver-protecting activity
06/04/2008CN101190911A N-[2-(5,5-dimethyl-1,3-dioxan-2-yl)-ethyl]amino acid and its synthesis and application
06/04/2008CN101190883A Novel compound with antiviral activity
06/04/2008CN101190330A Application of cholinesterase in antagonistic tachykinin medicine
06/04/2008CN101190326A Notoginseng keshi granule
06/04/2008CN101190303A Traditional Chinese medicine preparation for treating exogenous affected hyperthermia symptoms
06/04/2008CN101190290A Medicine for treating appendicitis
06/04/2008CN101190289A Traditional Chinese medicine for treating combined hemorrhoid postoperative edema pain
06/04/2008CN101190277A Method for preparing stemmacantha uniflora blood circulation-activating, stasis-removing and wind-damp-expelling wine
06/04/2008CN101190273A Traditional Chinese medicine emplastrum for repairing acute and chronic injury
06/04/2008CN101190257A Externally-used medicine bag for traditional Chinese medicinal composition for preventing and controlling infantile common cold
06/04/2008CN101190255A Kudzu root total flavone extracting after steam-explosion process
06/04/2008CN101190237A Anti-cold drugs containing dexibuprofen
06/04/2008CN101190229A Acetophen chewable tablets for dog
06/04/2008CN101190227A Betamethasone chewable tablets for dog or cat
06/04/2008CN101190216A Noramidopyrine chewable tablets for dog or cat
06/04/2008CN101190212A Naproxen chewable tablets for dog or cat
06/04/2008CN101190204A Acetaminopher dissolvable tablet for infant
06/04/2008CN101190195A N-acethy aminophenol chewable tablets for dog or cat
06/04/2008CN100391978C Recombinant anti-CD4 antibodies for human therapy
06/04/2008CN100391935C Cyclopentyl derivates
06/04/2008CN100391933C Substituted 1-aminobutan-3-01 derivatives
06/04/2008CN100391537C Complement pathway inhibitors binding to C5 and C5A without preventing formation of C5B
06/04/2008CN100391516C Shuihema medicated liquor
06/04/2008CN100391512C Medicine for promoting blood circulation, dispersing blood clots, eliminating swelling and pain, and dispelling wind and wetness
06/04/2008CN100391482C Saussurea involucrate powder injection
06/04/2008CN100391480C Hydrophilic gel pleximetric paste and its preparation method
06/04/2008CN100391457C Novel bulleyaconitine A powder injection
06/04/2008CN100391450C Compound medicine composition and its preparation and use
06/04/2008CN100391440C Formulation based on heparin, glycosaminogl ycan or heparinoid, use of the formulation and the formulation base
06/03/2008US7381840 2-Hydroxy-1,2,3,4-tetrahydronaphthalenes substituted in the 8-position with a biphenylcarbonylamino-, biphenylcarbonylaminoalkyl-, biphenylaminocarbonylamino-, or biphenylaminocarbonylaminoalkyl- group; vanilloid receptor antagonists
06/03/2008US7381790 Copolymers for suppression of autoimmune diseases, and methods of use
06/03/2008US7381726 Polymorphic forms of 1-′4-(5-cyanoindol-3-yl)butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
06/03/2008US7381412 Monoclonal antibody for use in diagnosis, prevention and treatment of inflammatory disorders
06/03/2008CA2389360C Urea derivatives as anti-inflammatory agents
06/03/2008CA2339628C Use of substance p antagonists for the treatment of chronic fatigue syndrome and/or fibromyalgia and use of nk-1 receptor antagonists for the treatment of chronic fatigue syndrome
06/03/2008CA2313024C Pharmaceutical compositions containing an omega-3 fatty acid oil
06/03/2008CA2244664C Composition comprising interleukin-1 inhibitor and controlled release polymer
05/2008
05/29/2008WO2008064018A1 Thienopyrimidinones for treatment of inflammatory disorders and cancers
05/29/2008WO2008063943A2 Method and use for increasing efficacy of anti-adhesive compositions in controlling inflammation and pain
05/29/2008WO2008063842A2 Methods of treating neuropathic pain with agonists of ppar-gamma
05/29/2008WO2008063670A1 Heterobicyclic matrix metalloprotease inhibitors
05/29/2008WO2008063669A1 Heterobicyclic matrix metalloprotease inhibitors
05/29/2008WO2008063668A1 Heterobicyclic metalloprotease inhibitors
05/29/2008WO2008063667A1 Heterotricyclic metalloprotease inhibitors
05/29/2008WO2008063603A2 Methods, compositions, and kits for treating pain and pruritis
05/29/2008WO2008063300A2 Boronic acids and esters as inhibitors of fatty acid amide hydrolase
05/29/2008WO2008063116A1 Indozalyl sulphonamide derivatives useful as glucocorticoid modulators
05/29/2008WO2008062861A1 Extract powder of indigo-containing plant, method for production thereof, and use thereof
05/29/2008WO2008062830A1 Spiroquinone compound and pharmaceutical composition
05/29/2008WO2008062026A1 5-sulfanylmethyl-pyrazolo [1,5-a] pyrimidin-7-ol derivatives as cxcr2 antagonists
05/29/2008WO2008061741A1 5-sulfanylmethyl-[1,2,4] triazol[1, 5-a] pyrimidin-7-ol derivatives as cxcr2 antagonists
05/29/2008WO2008061647A1 Use of a compound as vegf inhibitor